The financials
Haleon plc by the numbers
Haleon plc (HLN) reported revenue of £5.54B in H2 2024 (quarter ended December 31, 2024), down 2.3% from the same quarter a year earlier. That came with a gross margin of 59% and net income of £716M (13% of revenue). For the full year FY2025, revenue was £11.0B (−1.8% year on year) and net income £1.67B.
| Income statement | H2 2024 | H2 2022 | Change |
|---|---|---|---|
| Revenue | £5.54B | £5.67B | −2.3% |
| Gross profit | £3.28B | £3.37B | −2.7% |
| Operating income | £1.05B | £925M | +14% |
| Net income | £716M | £543M | +32% |
| Diluted EPS | £0.08 | £0.06 | +32% |
Drug Manufacturers - Specialty & Generic
The closest names by size in the same industry